Goldline Pharmaceutical SME GMP - Live Grey Market Premium

Ongoing
Goldline Pharmaceutical SME

Goldline Pharmaceutical Limited, incorporated in 2021, is a pharmaceutical marketing company that operates under an asset-light business model. The company markets a wide range of pharmaceutical formulations under its proprietary brand 'Goldline', across five specialized divisions: Pharma (General), Cardinal (Specialty), Aayushman (Pediatric), InLife (Critical Care), and Wellness (Supportive Care). Instead of in-house manufacturing, Goldline partners with 15 third-party manufacturers and utilizes a network of 7 distributors to supply products to retailers and hospitals across Maharashtra, Tamil Nadu, Rajasthan, and other states.

Issue Price
43
Current GMP
18
GMP %
+41.86
Est. Listing Price
61
Advertisement

IPO Details

Price Range
₹41.0 - ₹43.0
Issue Size
₹11.61 Cr
Lot Size
3000 shares
IPO Type
BSE SME
Open Date
12 May 2026
Close Date
14 May 2026
Allotment Date
15 May 2026
Listing Date
19 May 2026

GMP Timeline

DateIPO PriceGMPEst. Price% Change
12 May 2026Live
43
18
61
+41.86
11 May 2026
43
17
60
+39.53
10 May 2026
43
16
59
+37.21
9 May 2026
43
15
58
+34.88
8 May 2026
43
8
51
+18.60
7 May 2026
43
0
43
0.00
Advertisement

Important Notes About Grey Market Premium

Grey Market Premium (GMP) is an unofficial value that indicates investor sentiment before the IPO listing. It is the premium amount at which IPO shares are traded in the grey market before they are officially listed on the stock exchange.

GMP fluctuates based on market conditions and investor sentiment. A positive GMP suggests the market expects the stock to list above its issue price, while a negative GMP suggests it may list below the issue price.

The actual listing price may differ from the estimated price based on GMP due to market conditions on the listing day. GMP is not an official indicator and should not be the sole basis for investment decisions.

IPOwiz updates the GMP values regularly, but these values are sourced from unofficial channels and should be used as a reference only.

Back to GMP TrackerView Full IPO Details

Frequently Asked Questions

What is GMP (Grey Market Premium)?
GMP (Grey Market Premium) is the premium at which IPO shares are traded in the unofficial market before official listing. It indicates market sentiment and expected listing price. A positive GMP suggests strong demand, while negative GMP indicates weak market sentiment.
What is the current GMP for Goldline Pharmaceutical SME?
The current GMP for Goldline Pharmaceutical SME is ₹18. This represents a 41.86% premium over the issue price of ₹43.
What is the estimated listing price based on current GMP?
Based on the current GMP of ₹18 and issue price of ₹43, the estimated listing price for Goldline Pharmaceutical SME is ₹61. However, the actual listing price may differ based on market conditions on 19 May 2026.
How is GMP calculated?
GMP is determined by market demand and supply in the unofficial grey market. It's the difference between the expected listing price and the issue price. Higher GMP indicates strong demand and investor confidence, while lower or negative GMP suggests weak demand.
Is GMP reliable for IPO investment decisions?
GMP provides market sentiment but shouldn't be the sole factor for investment decisions. It's unofficial and can change daily. Consider company fundamentals, financials, market conditions, and your risk appetite before investing. GMP is a reference indicator, not a guarantee.
Can GMP change before listing?
Yes, GMP is highly volatile and can change daily based on market conditions, subscription levels, overall market sentiment, and news about the company. The GMP you see today may be different tomorrow, and it can change until 19 May 2026.
What happens if GMP is negative?
A negative GMP indicates the stock may list below the issue price, suggesting weak market demand. However, actual listing price may differ from GMP predictions, and negative GMP doesn't guarantee a loss.
How does GMP affect IPO subscription?
High GMP often correlates with high subscription rates as investors expect good listing gains. However, this isn't always true. Some IPOs with high GMP may have lower subscription if investors are cautious. GMP reflects market sentiment, which can influence subscription behavior.
What is the estimated profit based on GMP?
For a lot size of 3000 shares (2 lots for SME IPO), the estimated profit based on current GMP of ₹18 is ₹1,08,000. This is calculated as: Lot Size × GMP × Number of Lots. Note: This is an estimate and actual listing price may vary.